サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1790365

バイオフィルム対策創傷被覆材の米国市場規模、シェア、動向分析レポート：メカニズム別、用途別、最終用途別、地域別、セグメント別予測、2025～2030年

U.S. Anti-biofilm Wound Dressing Market Size, Share & Trends Analysis Report By Mode of Mechanism (Physical, Chemical, Biological), By Application (Chronic Wounds, Acute Wounds), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 80 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.55円
バイオフィルム対策創傷被覆材の米国市場規模、シェア、動向分析レポート：メカニズム別、用途別、最終用途別、地域別、セグメント別予測、2025～2030年
出版日: 2025年07月09日
発行: Grand View Research
ページ情報: 英文 80 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国のバイオフィルム対策創傷被覆材市場概要

米国のバイオフィルム対策創傷被覆材市場規模は、2024年に3億1,420万米ドルと評価され、2025～2030年にかけてCAGR 9.8%で成長し、2030年には5億4,630万米ドルに達すると予測されます。市場の成長は、糖尿病、がん、心血管疾患、その他の自己免疫疾患などの慢性疾患の増加により、慢性と急性の創傷の有病率が増加していることに起因しています。

米国疾病予防管理センターによると、2021年時点で3,800万人以上、米国全人口の11％以上が糖尿病を患っています。同国では交通事故が増加しており、市場の成長に大きく寄与しています。米国運輸省道路交通安全局によると、2024年には3万9,000人以上が交通事故で死亡しています。交通事故の増加は、こうした事故が重度の火傷や外傷につながる可能性があるため、抗バイオフィルム特性を備えた創傷ケア製品の需要を高めています。患者の転帰を改善しヘルスケアコストを削減するために、先進的な創傷ケア技術への政府と民間投資の増加が市場の成長にさらに貢献しています。

規制の枠組みは安全性と有効性を確保し、先進的抗菌性ドレッシングの採用を促進します。一方、最終用途の集中は、病院、専門クリニック、外来クリニックなどの主要ヘルスケアセグメントが需要を牽引する重要性を強調しています。

抗バイオフィルム機能を強化したドレッシングを開発するために各社が研究開発に多額の投資を行っているため、技術革新は依然として極めて重要です。2025年4月、Convatecは強力な抗菌・抗バイオフィルム剤である一酸化窒素を利用した新技術ConvaNioxの最初の市場投入計画を発表しました。ConvaNioxは当初、糖尿病性足潰瘍（DFU）の管理に使用される予定で、標準治療と比較して、創傷面積を3倍早く減少させ、DFUの治癒を60％増加させることが実証されています。

糖尿病の罹患率の上昇に加え、人口動態の高齢化も需要をさらに高めており、メーカー各社はこのセグメント特有の要件に対応するため、増産と製品ラインナップの拡充を急いでいます。例えば、多くの企業が米国内での製造能力を強化し、ヘルスケアプロバイダにより良いサービスを提供するために流通網を強化しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国のバイオフィルム対策創傷被覆材市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連市場展望
  • 産業バリューチェーン分析
  • 規制の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 産業の課題
    • 産業の機会
  • 産業分析ツール
    • ポーターのファイブフォース分析

第4章 米国のバイオフィルム対策創傷被覆材市場：メカニズム別、推定・動向分析

  • セグメントダッシュボード
  • 米国のバイオフィルム対策創傷被覆材市場：メカニズム変動分析と市場シェア、2024年と2030年
  • 物理的
    • 手動デブリードマン
    • パルス電界
    • 超音波デブリードマン
  • 化学品
    • イオン銀
    • ヨウ素
    • EDTA
    • その他
  • 生物学的
    • ディスパーシンB
    • ラクトフェリン
    • バクテリオファージ
    • その他

第5章 米国のバイオフィルム対策創傷被覆材市場：用途別、推定・動向分析

  • セグメントダッシュボード
  • 米国のバイオフィルム対策創傷被覆材市場：用途変動分析と市場シェア、2024年と2030年
  • 慢性創傷
    • 糖尿病性足潰瘍
    • 褥瘡
    • 静脈性下肢潰瘍
    • その他
  • 急性創傷
    • 外科的創傷と外傷
    • 火傷

第6章 米国のバイオフィルム対策創傷被覆材市場：最終用途別、推定・動向分析

  • セグメントダッシュボード
  • 米国のバイオフィルム対策創傷被覆材市場：最終用途変動分析と市場シェア、2024年と2030年
  • 病院
  • 専門クリニック
  • 在宅ヘルスケア
  • その他

第7章 米国のバイオフィルム対策創傷被覆材市場-競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業ヒートマップ
  • ポジション分析、2024年
  • 戦略マッピング
    • 拡大
    • 合併と買収
    • パートナーシップとコラボレーション
    • 新製品の発売
    • 研究開発
  • 企業プロファイル
    • ConvaTec Inc.
    • Smith & Nephew PLC
    • Imbed Biosciences
    • Next Science
    • B. Braun Melsungen AG
    • 3M
    • Molnlycke Health Care AB
    • Coloplast
    • Lohmann & Rauscher
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. anti-biofilm wound dressing market 2018 - 2030 (USD Million)
  • Table 3 U.S. anti-biofilm wound dressing market estimates and forecasts by mode of mechanism 2018 - 2030 (USD Million)
  • Table 4 U.S. anti-biofilm wound dressing market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. anti-biofilm wound dressing market estimates and forecasts by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 QFD Modeling for Market Share Assessment
  • Fig. 6 Information Procurement
  • Fig. 7 Market Formulation and Validation
  • Fig. 8 Data Validating & Publishing
  • Fig. 9 Market Segmentation & Scope
  • Fig. 10 U.S. Anti-biofilm Wound Dressing Market Snapshot
  • Fig. 11 Segment Snapshot (1/2)
  • Fig. 12 Segment Snapshot (1/2)
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent market outlook
  • Fig. 15 U.S. Anti-biofilm Wound Dressing Market Value, 2024 (USD Million)
  • Fig. 16 U.S. Anti-biofilm Wound Dressing Market - Value Chain Analysis
  • Fig. 17 U.S. Anti-biofilm Wound Dressing Market - Market Dynamics
  • Fig. 18 U.S. Anti-biofilm Wound Dressing Market - PORTER's Analysis
  • Fig. 19 U.S. Anti-biofilm Wound Dressing Market - PESTEL Analysis
  • Fig. 20 U.S. Anti-biofilm Wound Dressing Market Estimates & Forecasts, by Mode of Mechanism: Key Takeaways
  • Fig. 21 U.S. Anti-biofilm Wound Dressing Market Share, by Mode of Mechanism, 2024 & 2030
  • Fig. 22 Physical Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Manual Debridement Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Pulse Electrical Field Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Ultrasound Debridement Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Chemical Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Ionic Silver Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Iodine Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 EDTA Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Biological Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Dispersin B Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Lactoferrin Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Bacteriophage Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Anti-biofilm Wound Dressing Market Estimates & Forecasts, by Application: Key Takeaways
  • Fig. 37 Chronic Wounds Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Diabetic Foot Ulcers Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Pressure Ulcers Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Venous Leg Ulcers Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Acute Wounds Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Surgical & Traumatic Wounds Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Burn Wounds Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. Anti-biofilm Wound Dressing Market Estimates & Forecasts, by End-Use: Key Takeaways
  • Fig. 46 Hospitals Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Specialty Clinics Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Home Healthcare Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key Company Categorization
  • Fig. 51 Company Market Positioning
  • Fig. 52 Strategy Mapping
目次
Product Code: GVR-4-68040-666-0

U.S. Anti-Biofilm Wound Dressing Market Summary

The U.S. anti-biofilm wound dressing market size was valued at USD 314.2 million in 2024 and is projected to reach USD 546.3 million by 2030, growing at a CAGR of 9.8% from 2025 to 2030. The market's growth can be attributed to the growing prevalence of chronic and acute wounds owing to the increase in chronic diseases, including diabetes, cancer, cardiovascular diseases, and other autoimmune diseases.

According to the U.S. Centers for Disease Control and Prevention, as of 2021, over 38 million people, over 11% of the overall U.S. population, had diabetes. The country's increasing number of road accidents significantly contributes to the market's growth. According to the U.S. Department of Transportation's National Highway Traffic Safety Administration, over 39,000 people died in road accidents in 2024. The growing number of road accidents increases the demand for wound care products with anti-biofilm properties, as these accidents can lead to severe burns and traumatic injuries. The increasing government and private investments in advanced wound care technologies to improve patient outcomes and lower healthcare costs further contribute to the market's growth.

Regulatory frameworks ensure safety and efficacy and promote the adoption of advanced antimicrobial dressings, while end-use concentration highlights the significance of key healthcare segments such as hospitals, specialty clinics, and outpatient clinics in driving demand.

Innovation remains crucial as companies invest heavily in R&D to develop dressings with enhanced anti-biofilm capabilities. In April 2025, Convatec announced its plans for the initial market launch of ConvaNiox, a new technology powered by a potent antimicrobial and antibiofilm agent, nitric oxide, which is supported by strong clinical evidence. ConvaNiox will be initially used for the management of diabetic foot ulcers (DFUs), which has been demonstrated to reduce the wound area three times faster and increase DFU healing by 60% in comparison to the standard of care.

The rising incidence of diabetes, alongside an aging demographic, further increases the demand, urging manufacturers to increase production and broaden their product ranges to cater to the sector's specific requirements. For instance, numerous companies have enhanced their manufacturing capabilities within the U. S. and fortified their distribution networks to serve healthcare providers better.

U.S. Anti-biofilm Wound Dressing Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. anti-biofilm wound dressing market report based on mode of mechanism, application, and end-use:

  • Mode of Mechanism (Revenue, USD Million, 2018 - 2030)
  • Physical
    • Manual Debridement
    • Pulse Electrical Field
    • Ultrasound Debridement
  • Chemical
    • Ionic Silver
    • Iodine
    • EDTA
    • Others
  • Biological
    • Dispersin B
    • Lactoferrin
    • Bacteriophage
    • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Chronic Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Venous Leg Ulcers
    • Others
  • Acute Wounds
    • Surgical & Traumatic Wounds
    • Burn Wounds
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Anti-biofilm Wound Dressing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related Market Outlook
  • 3.2. Industry Value Chain Analysis
  • 3.3. Regulatory Framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Industry Challenges
    • 3.4.4. Industry Opportunities
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis

Chapter 4. U.S. Anti-biofilm Wound Dressing Market: Mode of Mechanism Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Anti-biofilm Wound Dressing Market: Mode of Mechanism Movement Analysis & Market Share, 2024 & 2030
  • 4.3. Physical
    • 4.3.1. Physical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Manual Debridement
      • 4.3.2.1. Manual Debridement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Pulse Electrical Field
      • 4.3.3.1. Pulse Electrical Field Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Ultrasound Debridement
      • 4.3.4.1. Ultrasound Debridement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Chemical
    • 4.4.1. Chemical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Ionic Silver
      • 4.4.2.1. Ionic Silver Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Iodine
      • 4.4.3.1. Iodine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. EDTA
      • 4.4.4.1. EDTA Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Biological
    • 4.5.1. Biological Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Dispersin B
      • 4.5.2.1. Disperin B Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Lactoferrin
      • 4.5.3.1. Lactoferrin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Bacteriophage
      • 4.5.4.1. Bacteriophage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Anti-biofilm Wound Dressing Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Anti-biofilm Wound Dressing Market: Application Movement Analysis & Market Share, 2024 & 2030
  • 5.3. Chronic Wounds
    • 5.3.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Diabetic Foot Ulcers
      • 5.3.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Pressure Ulcers
      • 5.3.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Venous Leg Ulcers
      • 5.3.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Others
      • 5.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Acute Wounds
    • 5.4.1. Acute Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Surgical & Traumatic Wounds
      • 5.4.2.1. Surgical & Traumatic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Burn Wounds
      • 5.4.3.1. Burn Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Anti-biofilm Wound Dressing Market: End-Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Anti-biofilm Wound Dressing Market: End-Use Movement Analysis & Market Share, 2024 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Specialty Clinics
    • 6.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Home Healthcare
    • 6.5.1. Specialty Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Anti-biofilm Wound Dressing Market - Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map
  • 7.4. Position Analysis, 2024
  • 7.5. Strategy Mapping
    • 7.5.1. Expansion
    • 7.5.2. Mergers & Acquisition
    • 7.5.3. Partnerships & Collaborations
    • 7.5.4. New Product Launches
    • 7.5.5. Research and Development
  • 7.6. Company Profiles
    • 7.6.1. ConvaTec Inc.
      • 7.6.1.1. Participant's overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Recent developments
    • 7.6.2. Smith & Nephew PLC
      • 7.6.2.1. Participant's overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Recent developments
    • 7.6.3. Imbed Biosciences
      • 7.6.3.1. Participant's overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Recent developments
    • 7.6.4. Next Science
      • 7.6.4.1. Participant's overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Recent developments
    • 7.6.5. B. Braun Melsungen AG
      • 7.6.5.1. Participant's overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Recent developments
    • 7.6.6. 3M
      • 7.6.6.1. Participant's overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Recent developments
    • 7.6.7. Molnlycke Health Care AB
      • 7.6.7.1. Participant's overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Recent developments
    • 7.6.8. Coloplast
      • 7.6.8.1. Participant's overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Recent developments
    • 7.6.9. Lohmann & Rauscher
      • 7.6.9.1. Participant's overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Recent developments